Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	4	3	7	23	27	47
Market Cap Growth	-52.98%	-47.96%	-71.05%	-15.81%	-42.16%	213.02%
Enterprise Value	-4	-7	-12	-2	9	24
PE Ratio	-	-0.25	-0.43	-1.57	-5.89	-1.64
PS Ratio	0.76	0.65	0.90	3.40	3.41	40.53
PB Ratio	0.38	0.27	0.32	0.74	0.99	6.15
P/FCF Ratio	-0.20	-0.23	-0.51	-0.86	-0.84	-2.54
P/OCF Ratio	-0.20	-0.23	-0.48	-0.89	-0.91	-2.76
EV/Sales Ratio	-0.86	-1.34	-1.61	-0.34	1.13	20.78
EV/EBITDA Ratio	0.77	0.55	0.85	0.19	-3.01	-0.87
EV/EBIT Ratio	0.67	0.51	0.78	0.16	-1.92	-0.84
EV/FCF Ratio	0.31	0.47	0.91	0.09	-0.28	-1.30
Debt / Equity Ratio	0.08	0.08	0.10	0.11	0.34	0.29
Debt / EBITDA Ratio	-0.14	-0.08	-0.14	-0.27	-3.09	-0.08
Debt / FCF Ratio	-0.05	-0.07	-0.15	-0.12	-0.29	-0.12
Quick Ratio	3.22	3.39	5.19	5.96	4.60	4.54
Current Ratio	4.05	4.17	6.03	7.02	5.02	4.98
Asset Turnover	0.25	0.21	0.22	0.11	0.21	0.04
Interest Coverage	-	-	-	-731.90	-100.68	-5759.60
Return on Equity (ROE)	-49.40%	-88.70%	-59.60%	-37.30%	-30.00%	-381.90%
Return on Assets (ROA)	-32.60%	-55.70%	-44.80%	-24.00%	-12.30%	-98.30%
Return on Capital (ROIC)	-117.64%	-100.65%	-61.07%	-103.92%	-34.46%	-212.08%
Earnings Yield	-171.70%	-402.29%	-230.24%	-63.54%	-16.99%	-60.79%
FCF Yield	-365.76%	-436.91%	-196.59%	-116.40%	-118.75%	-39.38%
Buyback Yield / Dilution	-57.53%	-106.37%	-12.66%	-113.68%	-56.51%	-68.94%
Total Shareholder Return	-57.53%	-106.37%	-12.66%	-113.68%	-56.51%	-68.94%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).